Virtus LifeSci Biotech Clinical Trials ETF (BBC) Holdings $25.96 -0.21 (-0.80%) (As of 01:50 PM ET) Add Compare Share Share Holdings Stock AnalysisChartHoldingsRatings Top 50 BBC HoldingsRankCompanyCurrent PriceWeightShares Held1LBPHLongboard Pharmaceuticals$59.772.36%4,6182SRRKScholar Rock$26.93-3.3%2.29%9,7713WVEWave Life Sciences$14.84+4.1%1.91%14,2224SMMTSummit Therapeutics$18.43-1.0%1.90%11,3905Bny Mellon Cash Reserve UsdN/A1.87%218,3526PRAXPraxis Precision Medicines$73.20-0.7%1.61%2,297 Get the Latest News and Ratings for BBC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Virtus LifeSci Biotech Clinical Trials ETF and its competitors with MarketBeat's FREE daily newsletter. 7ZYMEZymeworks$13.77-5.4%1.49%10,1148EWTXEdgewise Therapeutics$32.24+0.9%1.47%5,1459CNTACentessa Pharmaceuticals$17.00+1.6%1.44%9,28510ACLXArcellx$87.90+0.8%1.42%1,65111VRDNViridian Therapeutics$19.93+0.7%1.35%7,01112APLTApplied Therapeutics$9.40-0.3%1.34%17,52413BLTEBelite Bio$81.63-1.1%1.30%1,84314NRIXNurix Therapeutics$22.85+0.9%1.28%5,51215IRONDisc Medicine$63.79+2.0%1.27%2,35316BHVNBiohaven$45.74-2.3%1.16%2,76017RVMDRevolution Medicines$57.67+1.1%1.16%2,32118IGMSIGM Biosciences$8.99-8.0%1.11%11,60619KYMRKymera Therapeutics$43.16-2.0%1.10%2,64020SLRNAcelyrin$4.33-2.3%1.08%21,13821DNLIDenali Therapeutics$24.23-0.8%1.06%4,16422ORICORIC Pharmaceuticals$8.73-0.1%1.06%11,99723RNAAvidity Biosciences$43.39-0.6%1.04%2,30524VERAVera Therapeutics$47.21+3.2%1.04%2,46525ERASErasca$2.54-3.8%1.03%42,27526PCVXVaxcyte$87.22+1.5%1.03%1,24427QUREuniQure$5.71+0.2%1.02%17,55628SAVACassava Sciences$27.43+5.3%1.00%4,63429KROSKeros Therapeutics$54.25+0.2%1.00%1,85930NAMSNewAmsterdam Pharma$20.34+1.6%1.00%4,73831AKROAkero Therapeutics$30.69+0.2%0.99%3,74132CRNXCrinetics Pharmaceuticals$56.65+1.0%0.99%1,96233PTGXProtagonist Therapeutics$41.81+2.9%0.98%2,68034REPLReplimune Group$11.03-1.8%0.98%9,73935SLNOSoleno Therapeutics$53.85-1.8%0.98%2,05036APGEApogee Therapeutics$44.40-1.4%0.97%2,13837JANXJanux Therapeutics$47.44-3.1%0.97%2,17838MLTXMoonLake Immunotherapeutics$49.55-0.5%0.95%2,16239ELVNEnliven Therapeutics$25.39-0.2%0.93%4,18840EXAIExscientia$4.840.93%19,359Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW41ABUSArbutus Biopharma$3.49+1.5%0.91%29,16242COGTCogent Biosciences$9.13+0.6%0.91%10,26643PLRXPliant Therapeutics$13.04+2.4%0.91%7,69744NUVLNuvalent$92.53+1.5%0.90%1,16545ARQTArcutis Biotherapeutics$10.180.88%9,86746CRGXCARGO Therapeutics$15.69-0.8%0.88%5,36847PHVSPharvaris$20.500.87%5,08948XNCRXencor$23.87+0.6%0.87%4,32349XENEXenon Pharmaceuticals$40.06+1.8%0.87%2,42550ANNXAnnexon$5.36+3.9%0.86%15,339 Geographic ExposureUnited States83.9%Canada2.6%Netherlands2.1%Singapore1.9%Virgin Islands, British1.2%Cayman Islands1.0%Ireland0.6%Currency ExposureUSD100.0%Sector ExposureHealth Care25.5%Energy1.0%Industry ExposureBiotechnology22.8%Pharmaceuticals1.9%Renewable Energy1.0%Diversified Consumer Services0.7%SubIndustry ExposureBiotechnology18.5%Pharmaceuticals3.7%Renewable Energy Equipment1.0%Coupon Exposure0-22.2% Related Companies and Tools Related Companies JDOC Portfolio PILL Portfolio MEDX Portfolio FTXH Portfolio MEDI Portfolio BIS Portfolio HYLG Portfolio LGHT Portfolio RXD Portfolio GDOC Portfolio This page (NYSEARCA:BBC) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Clinical Trials ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Clinical Trials ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
